[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 66, "title": "Co-Founder, Executive VP & Chief Science Officer", "yearBorn": 1958, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.65, "open": 3.645, "dayLow": 3.6211, "dayHigh": 3.8, "regularMarketPreviousClose": 3.65, "regularMarketOpen": 3.645, "regularMarketDayLow": 3.6211, "regularMarketDayHigh": 3.8, "payoutRatio": 0.0, "beta": -0.883, "forwardPE": -0.5198358, "volume": 71204, "regularMarketVolume": 71204, "averageVolume": 102519, "averageVolume10days": 94300, "averageDailyVolume10Day": 94300, "bid": 3.63, "ask": 3.9, "bidSize": 1, "askSize": 1, "marketCap": 13861108, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 20.83, "fiftyDayAverage": 4.0901, "twoHundredDayAverage": 4.783315, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 7132310, "profitMargins": 0.0, "floatShares": 3759280, "sharesOutstanding": 3647660, "sharesShort": 92894, "sharesShortPriorMonth": 133391, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0255, "heldPercentInsiders": 0.02813, "heldPercentInstitutions": 0.02407, "shortRatio": 0.95, "shortPercentOfFloat": 0.026199998, "impliedSharesOutstanding": 3647660, "bookValue": 2.191, "priceToBook": 1.7343678, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -15545737, "trailingEps": -10.2, "forwardEps": -7.31, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -0.476, "52WeekChange": -0.5940171, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 3.8, "targetHighPrice": 62.0, "targetLowPrice": 8.0, "targetMeanPrice": 25.5, "targetMedianPrice": 16.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 12211321, "totalCashPerShare": 3.24, "ebitda": -14991883, "totalDebt": 5099079, "quickRatio": 2.462, "currentRatio": 2.546, "debtToEquity": 68.393, "returnOnAssets": -1.06539, "returnOnEquity": -53.05024, "grossProfits": -9445265, "freeCashflow": -12844647, "operatingCashflow": -18451388, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CING", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "esgPopulated": false, "regularMarketChangePercent": 4.109585, "regularMarketPrice": 3.8, "corporateActions": [], "postMarketTime": 1744406351, "regularMarketTime": 1744401600, "exchange": "NCM", "messageBoardId": "finmb_1674914781", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "marketState": "CLOSED", "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "postMarketChangePercent": 0.0, "postMarketPrice": 3.8, "postMarketChange": 0.0, "regularMarketChange": 0.14999986, "regularMarketDayRange": "3.6211 - 3.8", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 102519, "fiftyTwoWeekLowChange": 2.0, "fiftyTwoWeekLowChangePercent": 1.1111112, "fiftyTwoWeekRange": "1.8 - 20.83", "fiftyTwoWeekHighChange": -17.03, "fiftyTwoWeekHighChangePercent": -0.81757087, "fiftyTwoWeekChangePercent": -59.40171, "epsTrailingTwelveMonths": -10.2, "epsForward": -7.31, "epsCurrentYear": -2.89667, "priceEpsCurrentYear": -1.3118511, "fiftyDayAverageChange": -0.29009986, "fiftyDayAverageChangePercent": -0.07092733, "twoHundredDayAverageChange": -0.9833152, "twoHundredDayAverageChangePercent": -0.2055719, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-08", "averageAnalystRating": "2.0 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638973800000, "cryptoTradeable": false, "displayName": "Cingulate", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]